The Radiopharmaceuticals in Nuclear Medicine Market is estimated to be valued at US$ 9115.96 Mn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. The Radiopharmaceuticals in Nuclear Medicine Market: Radiopharmaceuticals are radioactive pharmaceuticals used in the diagnostic and...